The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO).
The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO).